(Q24796630)

English

Using modified antigenic sequences to develop cancer vaccines: are we losing the focus?

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Using modified antigenic sequences to develop cancer vaccines: are we losing the focus? (English)

0 references

0 references

Danila Valmori

1

0 references

Maha Ayyoub

series ordinal

2

0 references

language of work or name

English

0 references

publication date

November 2004

0 references

published in

PLOS MEDICINE

0 references

volume

1

0 references

issue

2

0 references

page(s)

e26

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

30 November 2004

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Diversity and recognition efficiency of T cell responses to cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529422

retrieved

7 April 2017

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529422

retrieved

7 April 2017

Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529422

retrieved

28 September 2017

Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529422

retrieved

28 September 2017

Cancer vaccines based on dendritic cells loaded with tumor-associated antigens

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529422

retrieved

28 September 2017

Cancer-induced defective cytotoxic T lymphocyte effector function: another mechanism how antigenic tumors escape immune-mediated killing

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529422

retrieved

28 September 2017

Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529422

retrieved

28 September 2017

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529422

retrieved

28 September 2017

T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histoc

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=529422

retrieved

28 September 2017

Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15578104

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic T cells recognize fragments of the influenza nucleoprotein

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15578104

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15578104

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PMED.0010026

0 references

PMC publication ID

529422

0 references

PubMed publication ID

15578104

0 references

ResearchGate publication ID

8149808

0 references

(Q24796630)

Using modified antigenic sequences to develop cancer vaccines: are we losing the focus?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)